ATOSSA THERAPEUTICS, INC. Finite-Lived License Agreements, Gross
ATOSSA THERAPEUTICS, INC. (ATOS) had Finite-Lived License Agreements, Gross of $0 as of 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization › Intangible Asset, Finite-Lived, before Accumulated Amortization
us-gaap:FiniteLivedLicenseAgreementsGross · last filed 2016-11-14
- 2016-09-30: Finite-Lived License Agreements, Gross $0.00.
- 2016-06-30: Finite-Lived License Agreements, Gross $0.00.
- 2016-03-31: Finite-Lived License Agreements, Gross $0.00.
- 2015-12-31: Finite-Lived License Agreements, Gross $200.00K.
| Period end | Finite-Lived License Agreements, Gross |
|---|---|
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-12 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 |
| 2015-12-31 | $200.00K 10-Q · filed 2016-11-14 |
| 2015-09-30 | $200.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $200.00K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $200.00K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $200.00K 10-K · filed 2016-03-30 |
| 2014-09-30 | $200.00K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $200.00K 10-Q · filed 2014-08-12 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |